July 28, 2022Recognition
Dr. Jekkie Kim, Amy Speros, and Susan Tull Named 2022 Women Worth Watching in STEM
Profiles in Diversity Journal honors three Latham lawyers who are advancing gender diversity in STEM fields.
Jekkie Kim advises healthcare, life sciences, and technology companies and their investors and lenders on a range of matters related to intellectual property, technology, and data. She draws on her background as a medical doctor, and has developed a particular focus on digital health, food technology, and cross-border transactions. Dr. Kim has extensive experience with strategic licensing and commercial transactions and guides clients through resolving complex IP issues by proposing creative, efficient, and effective strategies.
Dr. Kim advises clients at all stages, from emerging companies to global market leaders, in sectors including:
- Pharmaceutical and biotechnology
- Digital health
- Food technology
- Medical devices
She advises clients on transactional matters, including:
- Strategic licensing and collaborations
- University spin-outs
- Research, development, and agreements
- Manufacturing, supply, and distribution agreements
- Joint ventures
- Mergers and acquisitions
- IPOs and follow-on offerings
- Diverse financing transactions, including royalty purchase and sales
Her medical and business knowledge and perspectives as well as her experiences as a member of the Institutional Review Board (IRB) at Massachusetts General Hospital (MGH) enables Dr. Kim to quickly understand the ins and outs of her client’s business and enables her to advise diverse clients in the most effective way.
She regularly speaks and writes on healthcare, life sciences, and digital health related topics. She is an advisor to the Stanford University SPARK Program that allows Stanford students and professors to generate drug and diagnostic proofs-of-concept for potential commercialization, using academic approaches combined with industry standards.
Dr. Kim also maintains an active pro bono practice, helping clients protect and leverage their intellectual property, technology and data rights.